Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Pilocarpine Hydrochloride Ophthalmic Solution for Presbyopia
CTR20242701Phase 3Completed
- Sponsor
- Nanjing Zhengke Pharmaceutical
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Nanjing Zhengke Pharmaceutical. Started Jul 2024; status: completed.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20242701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242701.